|
|
Exchange: |
Nasdaq National Market |
Security
Type: |
Common |
Shares
Out: |
108,000,000 |
Market
Cap: |
N/A |
Last
Volume: |
5,721,727 |
Avg
Vol: |
2,654,246 |
52
Week Range: |
$73.89 - $73.89 |
|
Level
I Sector: |
Health Care |
Level
II Sector: |
Drugs |
Level
III Sector: |
Drug Manufacturers - Other |
|
Member Indexes:
|
NASDAQ BIOTECHNOLOGY |
|
NASDAQ COMPOSITE |
|
NASDAQ NNM COMPOSITE |
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : - |
Guru Rank Value : - |
Guru Occurances : - |
|
|
|
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
0 |
0 |
Total Buy Value |
$0 |
$0 |
$0 |
$0 |
Total People Bought |
0 |
0 |
0 |
0 |
Total Buy Transactions |
0 |
0 |
0 |
0 |
Total Shares Sold |
0 |
0 |
0 |
0 |
Total Sell Value |
$0 |
$0 |
$0 |
$0 |
Total People Sold |
0 |
0 |
0 |
0 |
Total Sell Transactions |
0 |
0 |
0 |
0 |
End Date |
2024-02-04 |
2023-11-03 |
2023-05-05 |
2022-05-05 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Steele Robin Joan |
SVP, GC, Secretary |
|
2011-12-09 |
4 |
D |
$16.54 |
$91,503 |
D/D |
(5,532) |
9,997 |
|
- |
|
Bradford Williamson Z III |
SVP-Clinical Science |
|
2011-12-09 |
4 |
D |
$16.54 |
$71,424 |
D/D |
(4,318) |
57,259 |
|
- |
|
Welch Daniel G |
Chairman, CEO and President |
|
2011-12-08 |
4 |
D |
$17.39 |
$405,897 |
D/D |
(23,340) |
217,600 |
|
- |
|
Russell Angus C. |
Director |
|
2011-10-31 |
4 |
A |
$0.00 |
$0 |
D/D |
5,058 |
5,058 |
|
- |
|
Di Nepi Giacomo |
SVP, Managing Director, Europe |
|
2011-10-07 |
4 |
OE |
$8.73 |
$286,735 |
D/D |
27,082 |
51,642 |
|
- |
|
Bradford Williamson Z III |
SVP-Clinical Science |
|
2011-07-27 |
4 |
AS |
$35.16 |
$63,286 |
D/D |
(1,800) |
61,577 |
|
- |
|
Bradford Williamson Z III |
SVP-Clinical Science |
|
2011-07-27 |
4 |
OE |
$8.73 |
$15,714 |
D/D |
1,800 |
63,377 |
|
- |
|
Porter Steven Bryant |
Chief Medical Officer |
|
2011-07-20 |
4 |
AS |
$36.25 |
$264,242 |
D/D |
(7,290) |
44,492 |
|
- |
|
Porter Steven Bryant |
Chief Medical Officer |
|
2011-07-20 |
4 |
OE |
$8.73 |
$63,642 |
D/D |
7,290 |
51,782 |
|
- |
|
Armstrong Marianne |
SVP Ch Reg & Drug Safety Off |
|
2011-07-20 |
4 |
AS |
$36.23 |
$262,694 |
D/D |
(7,250) |
44,492 |
|
- |
|
Armstrong Marianne |
SVP Ch Reg & Drug Safety Off |
|
2011-07-20 |
4 |
OE |
$8.73 |
$63,293 |
D/D |
7,250 |
51,742 |
|
- |
|
Bradford Williamson Z III |
SVP-Clinical Science |
|
2011-07-13 |
4 |
AS |
$35.97 |
$215,848 |
D/D |
(6,000) |
61,577 |
|
- |
|
Bradford Williamson Z III |
SVP-Clinical Science |
|
2011-07-13 |
4 |
OE |
$8.73 |
$52,380 |
D/D |
6,000 |
67,577 |
|
- |
|
Porter Steven Bryant |
Chief Medical Officer |
|
2011-07-06 |
4 |
AS |
$35.82 |
$261,118 |
D/D |
(7,290) |
44,492 |
|
- |
|
Porter Steven Bryant |
Chief Medical Officer |
|
2011-07-06 |
4 |
OE |
$8.73 |
$63,642 |
D/D |
7,290 |
51,782 |
|
- |
|
Armstrong Marianne |
SVP Ch Reg & Drug Safety Off |
|
2011-07-06 |
4 |
AS |
$35.84 |
$259,838 |
D/D |
(7,250) |
44,492 |
|
- |
|
Armstrong Marianne |
SVP Ch Reg & Drug Safety Off |
|
2011-07-06 |
4 |
OE |
$8.73 |
$63,293 |
D/D |
7,250 |
51,742 |
|
- |
|
Bradford Williamson Z III |
SVP-Clinical Science |
|
2011-06-29 |
4 |
AS |
$35.47 |
$212,836 |
D/D |
(6,000) |
61,577 |
|
- |
|
Bradford Williamson Z III |
SVP-Clinical Science |
|
2011-06-29 |
4 |
OE |
$12.74 |
$76,440 |
D/D |
6,000 |
67,577 |
|
- |
|
Armstrong Marianne |
SVP Ch Reg & Drug Safety Off |
|
2011-06-22 |
4 |
AS |
$35.02 |
$253,909 |
D/D |
(7,250) |
44,492 |
|
- |
|
Armstrong Marianne |
SVP Ch Reg & Drug Safety Off |
|
2011-06-22 |
4 |
OE |
$8.73 |
$63,293 |
D/D |
7,250 |
51,742 |
|
- |
|
Porter Steven Bryant |
Chief Medical Officer |
|
2011-06-22 |
4 |
AS |
$32.03 |
$233,462 |
D/D |
(7,290) |
44,492 |
|
- |
|
Porter Steven Bryant |
Chief Medical Officer |
|
2011-06-22 |
4 |
OE |
$8.73 |
$63,642 |
D/D |
7,290 |
51,782 |
|
- |
|
Armstrong Marianne |
SVP Ch Reg & Drug Safety Off |
|
2011-06-21 |
4 |
AS |
$35.00 |
$253,750 |
D/D |
(7,250) |
44,492 |
|
- |
|
Armstrong Marianne |
SVP Ch Reg & Drug Safety Off |
|
2011-06-21 |
4 |
OE |
$8.73 |
$63,293 |
D/D |
7,250 |
51,742 |
|
- |
|
772 Records found
|
|
Page 8 of 31 |
|
|